血清阿波利波蛋白E与中国患有叶的患者的认知功能之间的关联
Yuwei Han1, Guangzhi Hao1, Zhen Wang1
1Department of Neurology, General Hospital of Northern Theater Command, Shenyang, Liaoning, 110016, China.
Epilepsy & behavior : E&B
|March 29, 2024
概括
血清阿波利波蛋白E (APOE) 水平在叶患者中较高,并且与认知能力下降有关. 带有TLE的APOE ε4等位基因携带者表现出较差的认知功能.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 遗传学 是一个遗传学.
背景情况:
- (TLE) 是一种常见的神经疾病,通常与认知障碍有关.
- 脂蛋白E (APOE) 是一种脂质结合蛋白,参与各种生理过程,包括神经元功能和脂质代谢.
- APOE水平的变化及其遗传变异与神经退行性疾病和认知衰退有关.
研究的目的:
- 为了检查血清阿波利波蛋白E (APOE) 水平和诊断为叶 (TLE) 的患者的认知功能之间的关系.
- 研究APOE基因型,特别是e4等位基因对TLE患者认知表现的影响.
主要方法:
- 这项研究招募了190名患者,包括110名TLE患者和80名健康对照.
- 认知功能使用阿登布鲁克认知检查修订 (ACE-R) 尺度进行评估.
- 血清APOE水平通过ELISA量化,并使用微阵列杂交进行APOE基因定型.
主要成果:
- 与健康人相比,TLE患者在ACE-R上的得分明显较低,特别是在记忆和口语流方面.
- 与对照组相比,TLE患者的血清APOE水平明显升高.
- 在TLE患者的血清APOE水平和认知得分 (总,记忆和口语流) 之间观察到显著的负相关性.
- 与没有这种等位基因的TLE患者相比,携带APOE ε4等位基因的TLE患者表现出认知功能下降.
结论:
- 血清APOE水平升高是TLE群体的特征.
- 血清APOE水平明显与TLE认知功能障碍的存在和严重程度有关.
- APOE ε4等位基因与TLE患者的认知结果较差有关,这突显了它在相关认知障碍中的作用.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.9K
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
3.0K
相关概念视频
Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
